Hui Ran
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Advanced Glycation End Products research
Papers in
-
- Photodynamic Therapy Research Studies 4
-
- Natural Antidiabetic Agents Studies 2
- Co-authors
- Ruyuan Deng (3 shared papers)Qi Zhang (3 shared papers)Qing Su (3 shared papers)Qing Su (6 shared papers)Lanlan Liu (6 shared papers)Xuemei Tong (2 shared papers)Ai-Qing Ma (5 shared papers)Xisheng Liu (1 shared paper)
- Journals
- ACS Nano (2 papers)Scientific Reports (1 paper)Medicine (1 paper)Nano Research (1 paper)Diabetes Metabolic Syndrome and Obesity (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Hui Ran
17 papers receiving 367 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 92
- Clinical Biochemistry 31
- Molecular Biology 182
- Condensed Matter Physics 30
- Biochemistry 16
Countries citing papers authored by Hui Ran
This map shows the geographic impact of Hui Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ran more than expected).
Fields of papers citing papers by Hui Ran
This network shows the impact of papers produced by Hui Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ran. The network helps show where Hui Ran may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Ran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 91 | |
| 2 | 2017 | 41 | |
| 3 | 2022 | 38 | |
| 4 | 2008 | 37 | |
| 5 | 2023 | 33 | |
| 6 | 2017 | 31 | |
| 7 | 2021 | 30 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 12 | |
| 10 | 2020 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2021 | 7 | |
| 13 | 2024 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2022 | 2 | |
| 16 | 2025 | 1 | |
| 17 | [A pedigree study of a patient with primary pigmented nodular adrenocortical disease and familial gene mutation]. | 2014 | 1 |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Hui Ran
Hui Ran is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Biomedical Engineering, Molecular Biology and Condensed Matter Physics, having authored 21 papers that have together received 370 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Photodynamic Therapy Research Studies (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Micro and Nano Robotics (3 papers), Cancer Research and Treatments (2 papers), Natural Antidiabetic Agents Studies (2 papers), Advanced Glycation End Products research (2 papers) and Photoacoustic and Ultrasonic Imaging (2 papers). The work is most often cited by research in Cancer Research (92 citations), Clinical Biochemistry (31 citations), Molecular Biology (182 citations), Condensed Matter Physics (30 citations) and Biochemistry (16 citations). Hui Ran has collaborated with scholars based in China and United States. Frequent co-authors include Ruyuan Deng, Qi Zhang, Qing Su, Qing Su, Lanlan Liu, Xuemei Tong, Ai-Qing Ma, Xisheng Liu, Ming Feng and Jie Zhong. Their work appears in journals such as ACS Nano, Scientific Reports, Medicine, Nano Research and Diabetes Metabolic Syndrome and Obesity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.